Psoriasis is a chronic autoimmune skin condition characterized by accelerated skin cell turnover, leading to the formation of thick, red, scaly plaques. It commonly affects areas such as the scalp, elbows, knees, and lower back, but can occur anywhere on the body.
The condition is driven by immune system dysregulation, resulting in persistent inflammation and recurring flare-ups. In addition to physical symptoms like itching, scaling, and discomfort, psoriasis can also have a significant impact on quality of life, including emotional and social well-being.
While treatments such as topical therapies, phototherapy, and systemic medications—including biologics—can help manage symptoms, not all patients achieve consistent or long-term control. This highlights the importance of ongoing clinical research.
At Rejuvenation Dermatology, our psoriasis clinical trials are designed to evaluate innovative therapies that target the underlying immune pathways responsible for the condition. These studies aim to improve treatment effectiveness, reduce flare frequency, and enhance long-term disease management.
Participants receive access to investigational treatments within a structured, medically supervised environment. Each study follows strict ethical and regulatory guidelines, ensuring patient safety while contributing to the advancement of dermatologic care.
Our goal is to improve skin clearance, reduce inflammation, and support better long-term outcomes for individuals living with psoriasis.
EVIDENCE DRIVES BETTER PSORIASIS CARE
We believe psoriasis treatment should be guided by strong clinical evidence and long-term outcomes. Our clinical trials are designed to evaluate advanced therapies that target immune-driven inflammation and improve sustained skin clearance.
RESEARCH INTEGRATED INTO REAL CLINICAL PRACTICE
All studies are conducted within active dermatology clinics, ensuring patients receive care in a familiar and professional setting. Our dermatologists understand the clinical and lifestyle impact of psoriasis and provide comprehensive, patient-centered care.
ETHICS ARE NON-NEGOTIABLE
Every psoriasis trial undergoes independent ethics board review before enrollment begins. Participants are fully informed, carefully screened, and continuously monitored, with safety protocols that meet and exceed regulatory standards.
STANDARDIZED, NATIONAL EXECUTION
Our multi-site research network operates under centralized oversight and standardized protocols, ensuring consistent execution, high-quality data collection, and reliable outcomes across all participating locations.
Clinical research at Rejuvenation Dermatology is driven by a commitment to advance patient care through evidence-based medicine. Through participating in regulated clinical trials, the organization helps to shape development of safer, more effective dermatologic treatments while ensuring patients receive care that meets the highest ethical and scientific standards.
Participation in clinical research enables Rejuvenation physicians to remain at the forefront of dermatologic innovation and provides patients with access to therapies that may not yet be commercially available.
DERMATOLOGY-LED RESEARCH
Our psoriasis trials are led by experienced dermatologists with expertise in autoimmune skin diseases. Physician oversight ensures every participant receives clinically sound, research-driven care.
ADVANCED IMMUNE-TARGETED THERAPIES
Psoriasis is driven by complex immune pathways. Our trials focus on evaluating therapies that specifically target these pathways for more effective and sustained results.
SAFETY FIRST, ALWAYS
Patient safety is central to every study. Strict eligibility criteria, continuous monitoring, and adherence to Good Clinical Practice guidelines ensure a safe and controlled research environment.
CONSISTENT EXECUTION, TRUSTED RESULTS
Sponsors rely on our ability to recruit efficiently and deliver high-quality, audit-ready data. This structured approach ensures a reliable and seamless experience for participants.
ADVANCING FUTURE PSORIASIS TREATMENTS
Participation in clinical trials contributes to the development of new therapies that may significantly improve long-term outcomes for individuals living with psoriasis.
Yes, all trials follow strict medical and ethical standards.
Eligibility depends on the specific study but generally includes individuals with moderate to severe psoriasis.
Psoriasis is a chronic autoimmune skin condition that causes rapid skin cell buildup, leading to thick, scaly patches.
Participants may access new therapies while receiving expert dermatological care.
PSORIASIS CLINICAL TRIALS | CLINICAL TRIALS CANADA | REJUVENATION DERMATOLOGY
Rejuvenation Dermatology’s Clinical Trials Department is a national, multi-site research network dedicated to advancing dermatologic care through ethically conducted, regulated clinical research. Integrated within routine clinical practice, the department partners with global pharmaceutical sponsors to evaluate novel therapies and offers early access to innovative treatment options. The team supports industry-sponsored and investigator-initiated trials across a broad range of indications, collaborating closely with sponsors, CROs, investigators, and ethics boards to deliver high-quality data while maintaining a strong commitment to patient safety.
Since its inception, the division has evolved from a single research-focused clinic into a coordinated, multi-province research network. Today, it operates with standardized infrastructure, centralized oversight, and experienced investigators across Canada.
